Whalegun
Home

Biomarin Pharmaceutical BMRN spent $420K on lobbying in Q1 2023 · Health Issues, Medicare

Trade details

Type
Lobbying report
Amount
$420,000
Quarter
Q1 2023
Stock
Biomarin Pharmaceutical BMRN
Client
Biomarin Pharmaceutical
Reported
23/04/20

Up 0.0% from last quarter

What else happened in Biomarin Pharmaceutical around then

Filed or reported within 30 days of the trade day · 23/03/01~23/04/30

Biomarin Pharmaceutical's other lobbying reports